All In MedTech

Device Trial Radar · NCT06034652

T-GENVIH-003 LTFU (Long Term Follow Up) Study

A Prospective Analysis of the Use of Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair as Long Term Follow Up to T-GENVIH-002 Study

Last checked: Nov 19, 2026Latest source record: May 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

8

Actual

Start

Sep 12, 2023

Primary completion

Jan 19, 2024

Study completion Jan 19, 2024

Sponsor

Lead sponsor
Integra LifeSciences CorporationPublic (IART)
Sponsor type
Industry
First posted
Sep 13, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The T-GENVIH-003 study will collect additional, longer term performance data of Gentrix® Surgical Matrix used for reinforcement of ventral hernia repairs from a subset population (i.e., the twenty-one minimally invasive surgical approach cases) from the prior T-GENVIH-002 study.

Conditions

  • Hernia
  • Hernia, Ventral
  • Pathological Conditions, Anatomical
  • Hernia, Abdominal

Interventions

  • Integra® Gentrix® Surgical MatrixDevice

    Integra® Gentrix® Surgical Matrix is intended for implantation to reinforce soft tissue where weakness exists in patients requiring gastroenterological or plastic \& reconstructive surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Clinically Confirmed RecurrenceTime frame: Through study completion, an average of 4 months.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Surgical Healing Arts

    Fort Myers, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.